The global cerebral oximetry monitoring market size is estimated to be valued at US$ 217.24 million in 2023. The market is expected to grow 2X to surpass US$ 435.40 million by 2033, exhibiting a CAGR of 7.2% from 2023 to 2033.
Given the increasing need for non-invasive monitoring methods in healthcare settings, the cerebral oximetry monitoring market is booming. Patients are increasingly looking for non-invasive methods of monitoring and treatment as they grow more informed and engaged about their health.
For individuals who choose to avoid invasive treatments, cerebral oximetry monitoring is a desirable choice since it offers real-time monitoring of brain oxygen saturation levels. In several medical procedures, such as heart surgery, neurosurgery, and critical care, cerebral oximetry is an important technique for determining cerebral perfusion in real time.
The market is fueled by numerous reasons, including the expanding elderly population, the prevalence of chronic conditions such as cardiovascular diseases, and the increased public awareness of the advantages of cerebral oximetry monitoring. The market is also expected to expand as a direct consequence of technological developments like the incorporation of oximeters into patient monitoring systems.
Regulating the process of anesthesia this aids in ensuring that the brain receives adequate amounts of oxygen to preserve its health is one of the market’s key essential goals. By utilizing continuous, non-invasive near-infrared spectroscopy (NIRS) technology or near-infrared technology, cerebral oximeters have a significant role to play in acquiring brain oxygenation readings. Furthermore, a gradual increase in knowledge of neurodegenerative disorders is envisaged as a result of the government's increased attention to the development of strategies and discourses.
The use of wireless oximeters is expanding, research and development spending is rising, and wearable cerebral oximetry monitoring technology is beginning to appear on the market. In ambulatory, cerebral oximetry monitoring is another trend that is becoming more prevalent. By increasing the precision and effectiveness of diagnostic processes, the use of artificial intelligence (AI) and machine learning (ML) technologies in cerebral oximetry monitoring devices is anticipated to fuel market expansion.
There are many expansion opportunities, especially in developing nations where there is a rising need for cutting-edge medical technology. It could be possible to expand by creating new applications for cerebral oximetry monitoring in industries like sports medicine and aviation. Moreover, the growing need for remote patient monitoring and home healthcare services is anticipated to open up prospects for the design of novel, user-friendly cerebral oximetry monitoring technologies.
It has been emphasized that regulatory organizations like the United States Food and Drug Administration and European Medicines Agency approve new cerebral oximeter devices, providing market participants with business opportunities. While cerebral oximeters are one of the highly crucial tools used to track the amount of oxygen in the brain, the prevalence of neurological illnesses also increases the need for these instruments. Hence, throughout the forecast period, cerebral somatic oximeters market growth is projected to be driven by the increasing acceptance of these devices and the device industry's ongoing evolution.
| Attributes | Details |
|---|---|
| Cerebral Oximetry Monitoring Market Value (2023) | US$ 217.24 million |
| Cerebral Oximetry Monitoring Market Expected Value (2033) | US$ 435.40 million |
| Cerebral Oximetry Monitoring Market Projected CAGR (2023 to 2033) | 7.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The cerebral oximetry monitoring market witnessed significant growth from 2018 to 2022, and the trend is expected to continue from 2023 to 2033. The global market exhibited a CAGR of 5.8% during the historical period and is expected to register a CAGR of 7.2% during the forecast period.
The rise in surgical operations, the increase in the geriatric population, and the development of chronic conditions, including cardiovascular disease, cancer, and respiratory problems, all contributed to the substantial expansion of the global market. Technology improvements in the market have prompted the creation of monitoring systems that are more precise and effective.
The COVID-19 outbreak has had a detrimental effect on the cerebral oximetry monitoring market. The pandemic-related lockdown has delayed heart surgery as well as other non-essential procedures. The National Center for Biotechnology Information (NCBI) reports that between March 2020 and April 2021, during the pandemic, the rate of operations decreased by 37%. Nonetheless, revenue increased again when non-essential procedures worldwide gradually began owing to a backlog of postponed elective surgery.
The adoption of cerebral oximeters in conjunction with other technologies is anticipated to expand the market. For instance, in June 2022, Medtronic assimilated two unremitting monitoring technologies into the CARESCAPE platform from G.E. Healthcare, enabling physicians to customize treatment. For ICU and perioperative care, the technologies of Microstream capnography and INVOS regional oximetry are going to be utilized.
The FDA has given the integration the all-clear, and it has been given the CE Mark. With this, the CARESCAPE platform now offers all Medtronic patient monitoring technologies. The system also incorporates FlexAcuity from G.E. Healthcare, which enables doctors to select treatment alternatives depending on patient requirements and identify deterioration sooner. More alternatives for patient treatment are made available to practitioners throughout the world by this connection.
The cerebral oximetry monitoring market is expected to experience significant growth opportunities in the short-term, mid-term, and long-term future.
Short Term (2023 to 2026): The market is anticipated to be fueled by elements like the rising incidence of cardiovascular illnesses and the rising need for non-invasive monitoring methods. The industry is likely to gain from the growing understanding of the potential advantages of cerebral oximetry monitoring in enhancing patient outcomes.
Medium Term (2026 to 2029): Given the increasing acceptance of cutting-edge technologies such as wireless cerebral oximeters and the development of portable and user-friendly devices, the market is anticipated to have considerable growth prospects. These technical developments are projected to increase the availability and affordability of cerebral oximetry monitoring, which could fuel market expansion.
Long Term (2029 to 2033): The significance of early recognition and follow-up of neurological disorders, including stroke and traumatic brain damage, is likely to continue to expand, which could benefit the market. Furthermore, the requirement for cerebral oximetry monitoring is probably going to continue to increase over during this period due to the growing aging population and the increased prevalence of chronic disorders like dementia and Alzheimer's disease.
In 2022, North America possessed the maximum revenue share of 38% in the global market. This could be attributable to the presence and offers of significant players within the region.
The United States has the leading cerebral oximetry monitoring market in the world, with key manufacturers including Medtronic, Masimo Corporation, Nonin Medical, and CAS Medical Systems, all having a sizable presence. To monitor cerebral desaturation during cardiac surgery, oximeter devices, including the INVOS System, ForeSight System, EQUANOX, and Root with O3, are often supplied in the United States by Medtronic, Edwards Lifesciences Company, Nonin, and Masimo.
These all-monitoring devices can be used in operating rooms (OR), critical care units (ICU), and extracorporeal membrane oxygenation (ECMO). Thus, it is anticipated that growing research efforts to create new cerebral oximeter devices could propel market expansion. The non-invasive INVOS system from Medtronic was approved by the FDA in 2018 for use in newborns.
The market is anticipated to expand at a CAGR of 6.8% from 2023 to 2033, propelled by the aging population, rising incidence of chronic illnesses like Parkinson's and Alzheimer's, and the rising number of surgical operations. Healthcare professionals and patients in the United States are becoming increasingly aware of the advantages of cerebral oximetry monitoring. More people are using these devices as a result of increased awareness, which has contributed to market expansion.
The adoption of the western lifestyle, excessive smoking, alcohol consumption, and lack of physical activity led to an estimated 697,000 individuals in the United States having coronary artery disease (CAD) in 2020, according to the centers for disease control and prevention (CDC). The need for cerebral oximetry monitoring equipment to perform safe CAD surgery is anticipated to increase as the number of CAD cases rises.
Medicare medical device and service coverage is determined by the Centers for Medicare and Medicaid Services (CMS). Cerebral oximetry monitoring during cardiac and vascular surgeries was given CMS approval in 2019, which has contributed to an increase in the use of these devices in the United States.
The Europe cerebral oximetry monitoring market is expected to grow at a CAGR of 6.2% during the forecast period. The market is primarily driven by the increasing number of surgeries, the rising prevalence of chronic diseases, and advancements in technology. The market is dominated by key players such as Medtronic, Masimo Corporation, and CAS Medical Systems.
Medical equipment needs to obtain the CE Mark to be sold on the market in Europe. A device that bears the CE Mark has been certified to fulfill European Union standards for performance and safety. Before being advertised and sold in Europe, cerebral oximetry monitoring devices require CE Mark certification. National health systems that cover medical supplies and services are present in several European nations. These systems might decide on the coverage and payment procedures for cerebral oximetry monitoring equipment.
The usage of cerebral oximetry monitoring devices is rising in Europe, driven by a growing understanding of the advantages among healthcare professionals and the availability of reimbursement and coverage policies in many nations. New technology from manufacturers has increased accuracy, usability, and patient comfort. Masimo announced the introduction of its flagship Masimo O3® Regional Oximetry product range in Europe, including the United Kingdom, in March 2022. A new single-patient sticky sensor is part of the product range, giving doctors better accuracy and usability.
The use of cerebral oximetry monitoring systems differs greatly across European nations. For instance, although it could be less common in other nations, cerebral oximetry monitoring is often employed during pediatric heart surgery in the United Kingdom. The United Kingdom cerebral oximetry monitoring market is estimated to grow at a CAGR of 6.5% from 2023 to 2033. The use of cerebral oximetry monitoring in newborn surgery and critical care is advised by the United Kingdom Neonatal Clinical Network. In this country, the availability of non-invasive cerebral oximetry monitoring devices is rising.
Applications of tools, like the non-invasive INVOS system from Medtronic, are rising since they are easy to use and comfortable for patients. There is also rising interest in the creation of wearable cerebral oximetry monitoring technology. Patients who require long-term monitoring or who have mobility issues can use these devices to continuously monitor their brain oxygen saturation levels. These factors are propelling the market expansion in the United Kingdom.
Throughout the projected period, Asia Pacific is expected to exhibit a significant CAGR of 8.6% between 2023 and 2033. An aging population, a growth in the frequency of disorders, and an increase in per capita disposable incomes are the main drivers propelling the market in the region. Several studies have shown that older adults have a significant risk of cardiovascular disease (CVD) because of their high comorbidity rates. The old population in the nation was 138 million in 2021, and it is projected to grow to 194 million by 2031, according to the 2020 National Statistics Office report. In addition, it is anticipated that by 2050, there are going to be twice as many people who are 80 years of age or older.
The China cerebral oximetry monitoring market is projected to expand significantly, exhibiting a CAGR of 8.3% from 2023 to 2033. The market in this country is typically driven by increasing healthcare expenditure, the rising number of surgeries, and the growing aging population. In remote rural areas with a lack of healthcare resources, there is an increasing demand for cerebral oximetry monitoring technologies due to China's aging population and rising incidence of neurological disorders.
The "Healthy China 2020" plan is one of the key government activities for the cerebral oximetry monitoring industry in China. This initiative was launched by by The National Health and Family Planning Commission. Under this strategy, the nation's healthcare results are intended to be improved by the use of medical equipment and technology, such as cerebral oximetry monitoring.
Manufacturers in China are fostering growth through cooperation and new product development in addition to government measures. For instance, Nihon Kohden, a renowned producer of medical products, announced the release of its new wireless cerebral oximetry monitoring system in China in 2020. To increase its market share, the corporation has also partnered with regional Chinese businesses.
The Japan cerebral oximetry monitoring market is expected to grow at a CAGR of 7.2% from 2021 to 2028, driven by the increasing prevalence of neurological diseases and the rising number of surgeries. The application of cutting-edge medical technology, such as cerebral oximetry monitoring, has been extensively encouraged by the Japanese government. Healthcare establishments that invest in such technology receive tax breaks and government incentives. For instance, in 2020, the Japanese government launched a subsidy scheme to assist in the installation of non-invasive cerebral oximetry monitoring systems in hospitals and clinics all around the nation.
In Japan, key players in the market include CAS Medical Systems, Masimo, Medtronic, and Nonin Medical. These businesses are concentrating on creating cutting-edge items and growing their local distribution networks. For instance, the Invos Ultra 7 cerebral oximetry monitoring device, which offers real-time monitoring of brain oxygenation levels, was introduced by Medtronic in Japan in 2020. Through collaborations with regional distributors, the corporation has also been concentrating on extending its distribution network across the nation.
Principal Consultant
In 2022, the hospitals & clinics sector held the dominant position in the market with about a 53% share. Given the substantial demand for these devices in these settings, the hospitals and clinics sector leads the global market. To ensure the brain receives enough oxygen and prevents brain injury, surgical operations frequently involve cerebral oximetry monitoring. Many procedures are performed in hospitals and clinics, and cerebral oximetry monitoring is becoming a more common type of treatment. The ability of hospitals and clinics to purchase pricey medical devices like cerebral oximetry monitors is another factor contributing to the market expansion in this sector.
Maximum individuals attend hospitals and clinics because they have access to doctors and equipment needed for cardiac surgery. According to the AJMC publication, between 2014 and 2017, there were about 8, 273, 270 hospitalizations for heart failure. Maximum OR and ICU departments of hospitals employ cerebral oximeters to track patients' cerebral desaturation. As a result, rising hospital and clinic visits are anticipated to fuel market expansion.
Throughout the projection period, ambulatory surgical facilities are expected to have considerable expansion. Ambulatory surgical facilities all around the world perform a variety of operations related to various illnesses. There are more than 6,000 ambulatory facilities in the United States, according to the Ambulatory Surgery Association. So, a patient has quick access to therapy thanks to the widespread availability of ambulatory facilities, which also results in increased device usage.
In 2022, the adult market segment held a dominant market share of around 67% in terms of sales. Since adult populations have a greater prevalence of neurological problems and cardiovascular ailments, adults dominate the Cerebral Oximetry Monitoring market. Also, the need for cerebral oximetry monitoring devices is being driven by the increase in adult population operations, particularly heart and vascular procedures, which lowers the risk of postoperative cognitive impairment and other neurological problems.
The availability of cutting-edge technology, generous reimbursement practices, and elevated awareness of cerebral oximetry monitoring among patients and healthcare professionals are further contributing to the rise of the adult segment in this market. For example, Nonin Medical unveiled a new SenSmartTM Model X-100 cerebral oximetry monitoring system in 2021. The redesigned system has new wireless charging technology for better convenience and enhanced algorithms for more precise measurements.
Throughout the projection period, the pediatric category is expected to increase profitably. The expanded approval of devices for pediatric usage is accountable for this development. Masimo was granted an extension by the FDA in March 2022 to use its SedLine brain function system and sensors to track the brain activity of young children who are under anesthesia. In the upcoming years, category expansion is anticipated to be fueled by this approval.
Manufacturers in this sector have been putting several strategies into practice to acquire a competitive edge in the cerebral oximetry monitoring Market, which is a fast-expanding market. Among the crucial strategies used by the businesses in this market are:
Product Development: To fulfill the rising need for cerebral oximetry monitoring devices, one of the principal strategies used by manufacturers is to create cutting-edge and unique solutions. For example, Medtronic launched the Nellcor™ Bedside Respiratory Patient Monitoring system in 2021. The system provides continuous monitoring of patients' respiratory status and oxygenation levels, allowing clinicians to detect and respond to respiratory distress quickly.
Collaborations and Partnerships: To extend their market presence and broaden their product offerings, several firms are forming collaborations and partnerships with other businesses. For instance, the iSironaTM Pulse Oximetry Monitoring system was introduced by Masimo Corporation in 2020. By integrating Masimo's pulse oximetry technology with Sirona's dental practice management system, the solution enables doctors to track patients' oxygen saturation levels in real-time while performing dental operations.
Mergers and Acquisitions: Mergers and acquisitions are another tactic used by manufacturers. Companies improve their market share, diversify their product offerings, and enter new markets with this method. A United Kingdom-based firm called Digital Surgery, which creates artificial intelligence and machine learning solutions for surgery, was acquired by Medtronic in 2020, for instance.
Marketing and Advertising: To raise awareness of their products and improve brand recognition, manufacturers are spending money on marketing and advertising efforts. For instance, to advertise its cerebral oximetry monitoring devices in 2020, Natus Medical, a market leader, expanded its advertising budget.
Expansion into Emerging Markets: To take advantage of the rising demand for cerebral oximetry monitoring equipment, several manufacturers are spreading their businesses into developing nations. For instance, Nonin Medical Inc. declared in 2021 that its cerebral oximetry monitoring equipment in India had been given regulatory certification.
Diversification of Product Offerings: By creating supplementary goods and solutions that can be utilized in combination with their cerebral oximetry monitoring equipment, certain firms on the market are broadening their product offerings. Also, they are receiving accreditation for their products from regulatory bodies. For instance, the Chesapeake Regional Medical Center submitted a Certificate of Public Need (COPN) in January 2023, and the State Health Commissioner authorized it to meet the public need and implement open-heart surgery operations at the facility. Such activities could increase demand for cerebral oximetry monitoring devices, a crucial surgical instrument.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
China, Japan, and India are prominent Asian nations in the market.
The primary market for cerebral oximetry monitoring is the healthcare sector.
In Japan the market is anticipated to expand at a CAGR of 6% from 2023 to 2033.
The cerebral oximetry monitoring market is currently valued at US$ 217.24 million.
By 2033, the market is anticipated to grow to US$ 435.4 million.
1. Executive Summary | Cerebral Oximetry Monitoring Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
5.3.1. Cardiac Surgery
5.3.2. Vascular Surgery
5.3.3. Other Applications
5.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Age Group
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Age Group, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Age Group, 2023 to 2033
6.3.1. Paediatric
6.3.2. Adult
6.4. Y-o-Y Growth Trend Analysis By Age Group, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Age Group, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2023 to 2033
7.3.1. Hospitals & Clinics
7.3.2. Ambulatory Surgical Centres
7.4. Y-o-Y Growth Trend Analysis By End-use, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End-use, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Application
9.2.3. By Age Group
9.2.4. By End-use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Application
9.3.3. By Age Group
9.3.4. By End-use
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Application
10.2.3. By Age Group
10.2.4. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Application
10.3.3. By Age Group
10.3.4. By End-use
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Application
11.2.3. By Age Group
11.2.4. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Application
11.3.3. By Age Group
11.3.4. By End-use
11.4. Key Takeaways
12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Application
12.2.3. By Age Group
12.2.4. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Application
12.3.3. By Age Group
12.3.4. By End-use
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Application
13.2.3. By Age Group
13.2.4. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Application
13.3.3. By Age Group
13.3.4. By End-use
13.4. Key Takeaways
14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Application
14.2.3. By Age Group
14.2.4. By End-use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Application
14.3.3. By Age Group
14.3.4. By End-use
14.4. Key Takeaways
15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Application
15.2.3. By Age Group
15.2.4. By End-use
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Application
15.3.3. By Age Group
15.3.4. By End-use
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Application
16.1.2.2. By Age Group
16.1.2.3. By End-use
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Application
16.2.2.2. By Age Group
16.2.2.3. By End-use
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Application
16.3.2.2. By Age Group
16.3.2.3. By End-use
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Application
16.4.2.2. By Age Group
16.4.2.3. By End-use
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Application
16.5.2.2. By Age Group
16.5.2.3. By End-use
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Application
16.6.2.2. By Age Group
16.6.2.3. By End-use
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Application
16.7.2.2. By Age Group
16.7.2.3. By End-use
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Application
16.8.2.2. By Age Group
16.8.2.3. By End-use
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Application
16.9.2.2. By Age Group
16.9.2.3. By End-use
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Application
16.10.2.2. By Age Group
16.10.2.3. By End-use
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Application
16.11.2.2. By Age Group
16.11.2.3. By End-use
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Application
16.12.2.2. By Age Group
16.12.2.3. By End-use
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Application
16.13.2.2. By Age Group
16.13.2.3. By End-use
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Application
16.14.2.2. By Age Group
16.14.2.3. By End-use
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Application
16.15.2.2. By Age Group
16.15.2.3. By End-use
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Application
16.16.2.2. By Age Group
16.16.2.3. By End-use
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Application
16.17.2.2. By Age Group
16.17.2.3. By End-use
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Application
16.18.2.2. By Age Group
16.18.2.3. By End-use
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Application
16.19.2.2. By Age Group
16.19.2.3. By End-use
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Application
16.20.2.2. By Age Group
16.20.2.3. By End-use
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Application
16.21.2.2. By Age Group
16.21.2.3. By End-use
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Application
17.3.3. By Age Group
17.3.4. By End-use
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Masimo
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Medtronic
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Edwards Lifesciences Corporation
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Nonin
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. ISS, Inc.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Hamamatsu Photonics K.K.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Mespere LifeSciences
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. GE Healthcare
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Terumo Cardiovascular Systems Corporation
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Cerebral Oximetry Monitoring Market
